HIGHBRIDGE CAPITAL MANAGEMENT LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B906. A total of 5 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2022$3,647
-99.9%
325,000
-3.8%
0.10%
+108.3%
Q3 2022$3,427,000338,0000.05%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 325,000$3,6470.10%
GROUP ONE TRADING, L.P. 84,800$951,4560.00%
JANE STREET GROUP, LLC 105,600$1,184,8320.00%
SIMPLEX TRADING, LLC 118,700$1,3310.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THERAVANCE BIOPHARMA INC shareholders